Lin, L.Shi, Q.Nyarko, A.K.Bastow, K.F.Wu, C.Su, C.Lee, K.2013-06-162017-10-162013-06-162017-10-162006Lin, L., Shi, Q., Nyarko, A.K., Bastow, K. F., Wu, C.., Su, C., Lee, K. -. (2006). Antitumor agents. 250. design and synthesis of new curcumin analogues as potential anti-prostate cancer agents. Journal of Medicinal Chemistry, 49(13), 3963-3972.http://197.255.68.203/handle/123456789/3223In a continuing study of curcumin analogs as potential drug candidates to treat prostate cancer at both androgen-dependent and androgen-refractory stages, we designed and synthesized over 40 new analogs classified into four series: monophenyl analogs (series A), heterocycle-containing analogs (series B), analogs bearing various substituents on the phenyl rings (series C) and analogs with various linkers (series D). These new compounds were tested for cytotoxicity against two human prostate cancer cell lines, androgen-dependent LNCaP and androgen-independent PC-3. Antiandrogenic activity was also evaluated in LNCaP cells and PC-3 cells transfected with wild-type androgen receptor. Ten compounds possessed potent cytotoxicity against both LNCaP and PC-3 cells; seven only against LNCaP; and one solely against PC-3. This study established an advanced structure-activity relationship (SAR), and these correlations will guide the further design of new curcumin analogs with better anti-prostate cancer activity.enArticle